SEC Form 4 · accession 0001127602-18-001566
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Kuntz
Officer — SrVP & Chief Scien, Clin, Reg
Period of report
Jan 9, 2018
Accepted (ET)
Jan 10, 2018 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 9, 2018 | M | 35,492 | $37.53 | A | 149,761 | D | |
| Ordinary Shares | Jan 9, 2018 | M | 45,872 | $34.88 | A | 195,633 | D | |
| Ordinary SharesF1,F2 | Jan 9, 2018 | S | 78,526 | $86.21 | D | 117,107 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $37.53 | Jan 9, 2018 | M | 35,492 | D | — | Aug 2, 2020 | Ordinary Shares | 35,492 | 0 | D |
| Stock Option (Right to Buy)F4 | $34.88 | Jan 9, 2018 | M | 45,872 | D | — | Aug 1, 2021 | Ordinary Shares | 45,872 | 0 | D |
Explanation of responses
- F1This balance increased by 324 shares due to exempt transactions such as dividend reinvestment.
- F2The price reported in Column 4 is a weighted Average price. The shares were sold in multiple transactions at prices ranging from $86.12 to $86.26, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
- F3This option to purchase 35,492 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 35,492 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F4This option to purchase 45,872 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 45,872 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.